AMETEK, Inc.

AME · Healthcare · $54.2B mkt cap · FY2025 filings · Narrow moat

On the watchlist

Narrow moat

The four filters

Pricing power60

Median gross margin 34.6% over 10y, very stable.

Returns on capital68

Median ROIC 12.6%, above the 9% hurdle in 100% of years.

Balance-sheet safety89

Net debt/EBITDA 0.8x, interest coverage 24x.

Capital discipline80

Owner earnings +12.2%/yr, share count flat.

Margin of safety

Above valueOn sale

99% above value

Owner earnings (normalized): $1.5B
Est. intrinsic value / share: $119.05
Recent price: $236.51
Discount to value: 99% above value

Conservative model: 9% discount rate, 4% assumed growth (capped at 4%), maintenance capex ≈ min(capex, D&A).

Moat Score history

Score history begins 2026-07-17. Check back as the record builds.

Scores are logged append-only and never overwritten — this record can't be backfilled, which is exactly why it's worth keeping.

Embed this score on your site

One iframe, no script. The badge shows AME’s live Moat Score, updates itself as new filings are scored, and links back here. How it works.

<iframe
  src="https://buylikebuffett.com/embed/AME"
  width="340" height="150" style="border:0"
  title="AME Moat Score — The Moat Index"
  loading="lazy"></iframe>

Scored from primary SEC filings via the public methodology. Educational only — not a recommendation to buy or sell AME. See the disclaimer.